Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Cooper

Showing results (381-390 of 392) with videos related to

Pageof 40
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusionJ D Cooper, A Salehi, J D Delcroix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II TrialR L Burkes, R J Ginsberg, F A Shepherd, et al.
Gene Therapy|November 11, 2011
In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expressionA A Rahim, A M Wong, S Ahmadi, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Liposome-mediated gene transfer to lung isograftsC H Boasquevisque, T C Lee, B N Mora, et al.
Diabetologia|March 24, 2009
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetesM L Marcovecchio, R N Dalton, C P Schwarze, et al.
Genes and Immunity|March 19, 2004
Cost-effective analysis of candidate genes using htSNPs: a staged approachC E Lowe, J D Cooper, J M Chapman, et al.
Scientific Reports|July 11, 2019
CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)S L Eaton, C Proudfoot, S G Lillico, et al.
Gene Therapy|January 23, 2009
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectorsA A Rahim, A M S Wong, S J Howe, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Diabetologia|January 27, 2012
Confirmation of novel type 1 diabetes risk loci in familiesJ D Cooper, J M M Howson, D Smyth, et al.
Pageof 40

Showing results (381-390 of 392) with videos related to

Sort By:
Pageof 40
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusionJ D Cooper, A Salehi, J D Delcroix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II TrialR L Burkes, R J Ginsberg, F A Shepherd, et al.
Gene Therapy|November 11, 2011
In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expressionA A Rahim, A M Wong, S Ahmadi, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 31, 1997
Liposome-mediated gene transfer to lung isograftsC H Boasquevisque, T C Lee, B N Mora, et al.
Diabetologia|March 24, 2009
Ambulatory blood pressure measurements are related to albumin excretion and are predictive for risk of microalbuminuria in young people with type 1 diabetesM L Marcovecchio, R N Dalton, C P Schwarze, et al.
Genes and Immunity|March 19, 2004
Cost-effective analysis of candidate genes using htSNPs: a staged approachC E Lowe, J D Cooper, J M Chapman, et al.
Scientific Reports|July 11, 2019
CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease)S L Eaton, C Proudfoot, S G Lillico, et al.
Gene Therapy|January 23, 2009
Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectorsA A Rahim, A M S Wong, S J Howe, et al.
Neurobiology of Disease|October 21, 1999
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]H M Mitchison, D J Bernard, N D Greene, et al.
Diabetologia|January 27, 2012
Confirmation of novel type 1 diabetes risk loci in familiesJ D Cooper, J M M Howson, D Smyth, et al.
Pageof 40